{"id":"W2884380775","doi":"10.2337/dc18-0623","title":"Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Management and Research","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"AstraZeneca; Bristol-Myers Squibb","keywords":"Dapagliflozin; Medicine; Hypoglycemia; Placebo; Diabetes mellitus; Glycemic; Internal medicine; Diabetic ketoacidosis; Adverse effect; Insulin; Type 2 diabetes; Randomized controlled trial; Type 1 diabetes; Urology; Gastroenterology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005177637,0.001502112,0.003674224,0.0004119019,0.0003935771,0.001710319,0.0007597745,0.001914949,0.004723392],"category_scores_gemma":[0.005245274,0.0006340022,0.002558287,0.0005470061,0.0009578053,0.001036156,0.0004553159,0.002035532,0.0005568665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005320041,"about_ca_system_score_gemma":0.0008327303,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00047428,"about_ca_topic_score_gemma":0.001123242,"domain_scores_codex":[0.9977169,0.001514071,0.0001668005,0.0003082718,0.0001868127,0.0001071677],"domain_scores_gemma":[0.9973457,0.0008942775,0.001032003,0.0002218432,0.0001542973,0.0003518476],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9800428,0.002516571,0.001153514,0.001104549,0.002035854,0.00002933381,0.00004927437,0.000222016,0.001498336,0.00008361487,0.0009389325,0.0103251],"study_design_scores_gemma":[0.9612435,0.03328457,0.002889748,0.00008265866,0.001228874,0.00002711244,0.00001511298,0.0002803519,0.0002189469,0.00008633605,0.0006257187,0.00001709593],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9596116,0.02430293,0.001681307,0.001294416,0.000910427,0.005179715,0.003226012,0.0002774922,0.003516003],"genre_scores_gemma":[0.9760336,0.007714113,0.003025387,0.001572958,0.001458514,0.005850562,0.002460456,0.00004962725,0.001834796],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005177637,"threshold_uncertainty_score":0.02738225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01388334851724713,"score_gpt":0.258403644830267,"score_spread":0.2445202963130198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}